Bioregenx (BRGX) Cash & Current Investments (2021 - 2026)
Bioregenx's (BRGX) quarterly Cash & Current Investments came in at $45806.0 in Q1 2026, down 45.22% year-on-year from $83625.0 in Q1 2025, and down 33.98% quarter-over-quarter from $69383.0 in Q4 2025.
Bioregenx (BRGX) Cash & Current Investments (2021 - 2026) Analysis & Trends
Bioregenx's Cash & Current Investments history runs 6 years deep, the most recent figure standing at $45806.0 for Q1 2026.
- On a quarterly basis, Cash & Current Investments fell 45.22% year-over-year to $45806.0 in Q1 2026; TTM through Mar 2026 was $45806.0, a 45.22% decrease from a year earlier, with the FY2025 full-year figure at $69383.0, up 18.8% from the prior year.
- Cash & Current Investments slipped to $45806.0 in Q1 2026 per BRGX's latest filing, from $69383.0 in the prior quarter.
- Across five years, Cash & Current Investments topped out at $125402.0 in Q4 2023 and bottomed at $676.0 in Q4 2022.
- The 5-year median for Cash & Current Investments is $46947.0 (2025), against an average of $48412.9.
- Across the five-year window, Cash & Current Investments plunged 97.22% in 2022 and surged 18450.59% in 2023, its largest moves.
- Year by year, Cash & Current Investments stood at $676.0 in 2022, then jumped by 18450.59% to $125402.0 in 2023, then slumped by 53.43% to $58404.0 in 2024, then grew by 18.8% to $69383.0 in 2025, then plunged by 33.98% to $45806.0 in 2026.
- Per Business Quant, the three latest BRGX Cash & Current Investments figures stand at $45806.0 (Q1 2026), $69383.0 (Q4 2025), and $46947.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.29 Bn | 24.98 Bn | 662.02 Mn | 7.31 Bn |
| 2 | BrightSpring Health Services | 14.63 Bn | 13.73 Bn | 482.22 Mn | 901.03 Mn |
| 3 | Healthequity | 8.43 Bn | 8.16 Bn | 256.31 Mn | 265.37 Mn |
| 4 | Hinge Health | 5.96 Bn | 5.65 Bn | 154.23 Mn | 315.87 Mn |
| 5 | 10x Genomics | 5.88 Bn | 5.34 Bn | 106.18 Mn | 539.85 Mn |
| 6 | MiniMed | 4.52 Bn | 4.22 Bn | 480.00 Mn | 298.00 Mn |
| 7 | Waystar Holding | 4.47 Bn | 4.41 Bn | 216.84 Mn | 62.70 Mn |
| 8 | Doximity | 3.97 Bn | 3.22 Bn | 125.97 Mn | 748.60 Mn |
| 9 | Privia Health | 3.12 Bn | 2.70 Bn | - | 419.52 Mn |
| 10 | Bioregenx | 9.69 Mn | 9.65 Mn | 348,288.00 | 45,806.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45,806.00 |
| Dec 31, 2025 | 69,383.00 |
| Sep 30, 2025 | 46,947.00 |
| Jun 30, 2025 | 46,456.00 |
| Mar 31, 2025 | 83,625.00 |
| Dec 31, 2024 | 58,404.00 |
| Sep 30, 2024 | 70,081.00 |
| Jun 30, 2024 | 57,395.00 |
| Mar 31, 2024 | 114,158.00 |
| Dec 31, 2023 | 125,402.00 |
| Sep 30, 2023 | 758.00 |
| Dec 31, 2022 | 676.00 |
| Sep 30, 2022 | 1,541.00 |
| Jun 30, 2022 | 2,123.00 |
| Mar 31, 2022 | 3,438.00 |
| Dec 31, 2021 | 24,358.00 |